SanBio Company Limited (TYO:4592)
Japan · Delayed Price · Currency is JPY 879.00
-27.00 (-2.98%)
Sep 16, 2026, 3:10 PM JST
SanBio Company Balance Sheet
Financials in millions JPY. Fiscal year is February - January.
Millions JPY. Fiscal year is Feb - Jan.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Cash & Equivalents | 12,748 | 15,083 | 2,921 | 4,454 | 6,732 | 4,557 |
Cash & Short-Term Investments | 12,748 | 15,083 | 2,921 | 4,454 | 6,732 | 4,557 |
Cash Growth | 365.59% | 416.36% | -34.42% | -33.84% | 47.73% | -63.49% |
Inventory | 142 | - | - | - | - | 467 |
Other Current Assets | 490 | 406 | 414 | 483 | 235 | 327 |
Total Current Assets | 13,380 | 15,489 | 3,335 | 4,937 | 6,967 | 5,351 |
Property, Plant & Equipment | 185 | 69 | 40 | 44 | 47 | 58 |
Long-Term Investments | 35 | 18 | 27 | 21 | 28 | 34 |
Other Intangible Assets | 43 | 43 | 43 | 43 | 1 | 66 |
Other Long-Term Assets | 2 | 2 | 2 | 2 | 2 | 1 |
Total Assets | 13,645 | 15,621 | 3,447 | 5,047 | 7,045 | 5,510 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Accounts Payable | - | 1 | 1 | 1 | 1 | 1 |
Accrued Expenses | 116 | 224 | 313 | 494 | 374 | 472 |
Current Portion of Long-Term Debt | - | 129 | 268 | 268 | 268 | 512 |
Current Income Taxes Payable | 203 | 166 | 139 | 133 | 331 | 462 |
Other Current Liabilities | 20 | 14 | 11 | 9 | 116 | 16 |
Total Current Liabilities | 339 | 534 | 732 | 905 | 1,090 | 1,463 |
Long-Term Debt | 1,125 | 1,109 | 129 | 397 | 665 | 2,012 |
Long-Term Deferred Tax Liabilities | 431 | 372 | 823 | 952 | 860 | - |
Other Long-Term Liabilities | 25 | 1 | 1 | 1 | 2 | - |
Total Liabilities | 1,920 | 2,016 | 1,685 | 2,255 | 2,617 | 3,475 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Common Stock | 6,697 | 8,375 | 2,496 | 3,316 | 6,407 | 4,075 |
Additional Paid-In Capital | 10,408 | 12,086 | 6,207 | 7,027 | 10,118 | 7,786 |
Retained Earnings | 621 | -995 | -698 | -1,950 | -8,177 | -9,057 |
Treasury Stock | -1 | -1 | -1 | - | - | - |
Comprehensive Income & Other | -6,000 | -5,860 | -6,242 | -5,601 | -3,920 | -769 |
Shareholders' Equity | 11,725 | 13,605 | 1,762 | 2,792 | 4,428 | 2,035 |
Total Liabilities & Equity | 13,645 | 15,621 | 3,447 | 5,047 | 7,045 | 5,510 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Total Debt | 1,125 | 1,238 | 397 | 665 | 933 | 2,524 |
Net Cash (Debt) | 11,623 | 13,845 | 2,524 | 3,789 | 5,799 | 2,033 |
Net Cash Growth | 741.03% | 448.53% | -33.39% | -34.66% | 185.24% | -76.03% |
Net Cash Per Share | 152.49 | 189.35 | 36.65 | 58.00 | 100.12 | 39.26 |
Filing Date Shares Outstanding | 78.06 | 78.04 | 72.01 | 68.63 | 64.85 | 53.25 |
Total Common Shares Outstanding | 78.06 | 78.03 | 70.93 | 67.93 | 64.08 | 51.79 |
Working Capital | 13,041 | 14,955 | 2,603 | 4,032 | 5,877 | 3,888 |
Book Value Per Share | 150.21 | 174.35 | 24.84 | 41.10 | 69.11 | 39.29 |
Tangible Book Value | 11,682 | 13,562 | 1,719 | 2,749 | 4,427 | 1,969 |
Tangible Book Value Per Share | 149.66 | 173.80 | 24.24 | 40.47 | 69.09 | 38.02 |